These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23063018)

  • 1. Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism.
    Cuppett CD; Zhao Y; Caritis S; Zhang S; Zhao W; Venkataramanan R
    Am J Obstet Gynecol; 2013 Jan; 208(1):86.e1-6. PubMed ID: 23063018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.
    Amaral LM; Cornelius DC; Harmon A; Moseley J; Martin JN; LaMarca B
    Hypertension; 2015 Jan; 65(1):225-31. PubMed ID: 25368030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 Production.
    Megli CJ; Hauspurg A; Venkataramanan R; Caritis SN
    Am J Perinatol; 2023 Oct; 40(14):1585-1589. PubMed ID: 34784615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).
    Zhang S; Mada SR; Sharma S; Torch M; Mattison D; Caritis S; Venkataramanan R
    J Pharm Biomed Anal; 2008 Dec; 48(4):1174-80. PubMed ID: 18947956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.
    Caritis SN; Sharma S; Venkataramanan R; Hankins GD; Miodovnik M; Hebert MF; Umans JG; Benedetti T; Mattison D; Zajicek A; Fischer D; Jackson A;
    Am J Obstet Gynecol; 2012 Nov; 207(5):398.e1-8. PubMed ID: 22967833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.
    Caritis SN; Simhan HN; Zhao Y; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin SM; Harper M;
    Am J Obstet Gynecol; 2012 Nov; 207(5):396.e1-8. PubMed ID: 22959763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation and route of administration on the distribution of 17-hydroxyprogesterone caproate in rats.
    Shaik IH; Chaphekar N; Vasudevan V; Alshabi A; Bastian JR; Zhao W; Caritis S; Venkataramanan R
    Xenobiotica; 2023 Mar; 53(3):193-200. PubMed ID: 37039113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.
    Sharma S; Ellis EC; Gramignoli R; Dorko K; Tahan V; Hansel M; Mattison DR; Caritis SN; Hines RN; Venkataramanan R; Strom SC
    Drug Metab Dispos; 2013 Feb; 41(2):296-304. PubMed ID: 23129211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth.
    Sharma S; Ou J; Strom S; Mattison D; Caritis S; Venkataramanan R
    Drug Metab Dispos; 2008 Sep; 36(9):1896-902. PubMed ID: 18573861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.
    Sharma S; Ellis EC; Dorko K; Zhang S; Mattison DR; Caritis SN; Venkataramanan R; Strom SC
    Drug Metab Dispos; 2010 May; 38(5):723-7. PubMed ID: 20097724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone Metabolites Produced by Cytochrome P450 3A Modulate Uterine Contractility in a Murine Model.
    Patil AS; Swamy GK; Murtha AP; Heine RP; Zheng X; Grotegut CA
    Reprod Sci; 2015 Dec; 22(12):1577-86. PubMed ID: 26037300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
    Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
    Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate.
    Hemauer SJ; Yan R; Patrikeeva SL; Mattison DR; Hankins GD; Ahmed MS; Nanovskaya TN
    Am J Obstet Gynecol; 2008 Aug; 199(2):169.e1-5. PubMed ID: 18674659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins.
    Attardi BJ; Zeleznik A; Simhan H; Chiao JP; Mattison DR; Caritis SN;
    Am J Obstet Gynecol; 2007 Dec; 197(6):599.e1-7. PubMed ID: 18060946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of esterases on 17alpha-hydroxyprogesterone caproate.
    Yan R; Fokina V; Hankins GD; Ahmed MS; Nanovskaya TN
    Am J Obstet Gynecol; 2008 Feb; 198(2):229.e1-5. PubMed ID: 17936237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.
    Sharma S; Caritis S; Hankins G; Miodovnik M; Hebert MF; Mattison D; Venkataramanan R
    Br J Clin Pharmacol; 2016 Oct; 82(4):1084-93. PubMed ID: 27133963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.
    Caritis SN; Sharma S; Venkataramanan R; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M;
    Am J Obstet Gynecol; 2011 Jul; 205(1):40.e1-8. PubMed ID: 21620357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate.
    Caritis SN; Zhao Y; Bettinger J; Venkataramanan R
    Am J Obstet Gynecol; 2013 Jun; 208(6):470.e1-5. PubMed ID: 23453884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 17 alpha-hydroxyprogesterone 17-n-caproate on adrenal steroid excretion.
    CLARK SL; GREENBLATT RB
    Ann N Y Acad Sci; 1958 Jul; 71(5):710-6. PubMed ID: 13583826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.